Quantifying Quantum Computing And AI Drug Development | The Brainstorm EP 72

youtube
Quantifying Quantum Computing And AI Drug Development | The Brainstorm EP 72 Is quantum computing the next big thing? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Chief Futurist Brett Winton to discuss the latest advancements in quantum computing and AI drug discovery. They discuss Google's recent quantum chip announcement, the challenges of scaling quantum technology, and the potential applications in drug discovery. The conversation shifts to the partnership between GlaxoSmithKline and Relation Therapeutics, highlighting the promise of AI in revolutionizing drug development processes, reducing costs, and improving efficiency. The episode concludes with insights on the future of drug development and the potential for significant market changes in the pharmaceutical industry. If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today. Key Points From
  2024/12/18      youtube
Xポスト

latest news

雪印メグミルク株式会社主催 個人投資家向けオンライン会社説明会

雪印メグミルクは、牛乳・乳製品を中心に事業を展開し、近年では機能性食品や海外事業...

  2025/12/04

The football player to founder pipeline

Leading an NFL team and a company isn’t ...

  2025/12/04

Take your Investing to the Next Level with Seeking Alpha's AI Virtual

Discover how Seeking Alpha's new AI feat...

  2025/12/04

Interactive Brokers (IBKR): Massive Cash Flow & Dividend Safety | 2 Mi

Is Interactive Brokers (IBKR) a Buy or a...

  2025/12/04

Meta’s Metaverse Cuts Not Surprising: EMARKETER’s Smiley

Minda Smiley, senior analyst at EMARKETE...

  2025/12/04

UiPath Earnings Show Accelerating Growth

UiPath CEO Daniel Dines says AI is a com...

  2025/12/04

China Bolsters Support for Domestic AI Chipmakers

中国

Beijing-based Cambricon is set to triple...

  2025/12/04

Meta Plans Big Cuts to Its Metaverse Efforts

Meta is expected to meaningfully cut res...

  2025/12/04

X-Light's Nicholas Kelez and Pat Gelsinger on government-backed chips

Pat Gelsinger spent 35 years across two ...

  2025/12/04

The Road Ahead for Driverless Trucking

ロボット

The Trump team is setting its sights on ...

  2025/12/04

Alphabet AI Chips Seen as Growth Driver as Gemini 3 Wins Praise

Google

Alphabet investors are growing increasin...

  2025/12/04

Celebrity Co-Founders Not Required: Building Influence from Scratch

Alltroo co-founders Kyle Rudolph and Jon...

  2025/12/04

Why Two Presidents Accused of Drug Trafficking Face Different Fates Un

President Trump’s approach to Latin Amer...

  2025/12/04

Celestica (CLS) Stock: Why the Strong Buy Rating? | 2 Minute Analysis

Is Celestica (CLS), the $35.68 billion i...

  2025/12/04

Why hasn't Keir Starmer made bigger reforms?

The Economist's editor-in-chief, Zanny M...

  2025/12/04

Is two hinges better than one?

Is two hinges better than one?...

  2025/12/04